Gainers
- Acorda Therapeutics ACOR stock increased by 29.5% to $14.5 during Wednesday's after-market session. The market value of their outstanding shares is at $18.0 million.
- Vivos Therapeutics VVOS shares moved upwards by 20.52% to $0.37. Vivos Therapeutics's trading volume hit 16.2 million shares by close, accounting for 1061.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $10.9 million.
- Pasithea Therapeutics KTTA shares rose 16.53% to $0.47. The company's market cap stands at $9.7 million.
- Enveric Biosciences ENVB shares moved upwards by 9.44% to $2.78. The company's market cap stands at $6.0 million.
- 60 Degrees SXTP shares increased by 9.26% to $0.76. The market value of their outstanding shares is at $4.3 million.
- Esperion Therapeutics ESPR stock rose 8.08% to $0.98. Trading volume for this security closed at 205.5K, accounting for 5.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $104.8 million.
Losers
- MaxCyte MXCT shares declined by 18.4% to $2.67 during Wednesday's after-market session. Trading volume for this security closed at 56.9K, accounting for 13.1% of its average full-day volume over the last 100 days. The company's market cap stands at $276.3 million.
- Heart Test Laboratories HSCS stock fell 15.87% to $0.35. The market value of their outstanding shares is at $3.8 million.
- Senti Biosciences SNTI stock decreased by 9.55% to $0.36. Today's trading volume for this security ended up closing at 7.2 million shares, which is 9000.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $16.0 million.
- Accolade ACCD shares fell 7.59% to $9.01. Trading volume for this security closed at 135.7K, accounting for 28.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $681.4 million. The company's, Q2 earnings came out today.
- Elutia ELUT shares declined by 7.52% to $1.23. The market value of their outstanding shares is at $28.4 million.
- PDS Biotechnology PDSB stock declined by 5.44% to $4.0. The company's market cap stands at $123.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in